Mezgebe Berhe MD

Physician

3409 Worth St710Dallas, TX 75246
Phone+1 214-823-2533
Fax+1 214-824-8679

Dr. Berhe is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Berhe's full profile Already have an account?

Education & Training

Virginia Commonwealth University Health SystemFellowship, Infectious Disease, 2003 - 2005
St Barnabas HospitalResidency, Internal Medicine, 2000 - 2003
Addis Ababa University Faculty of MedicineClass of 1993

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

TX State Medical License 2005 - 2028
VA State Medical License 2003 - 2006
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Vitera Intergy Meaningful Use Edition, Vitera Healthcare Solutions, LLC, 2012-2015, 2017
CMS Meaningful Use Stage 1 Certification Sage Intergy Meaningful Use Edition, Sage, 2012-2015, 2017
CMS Meaningful Use Stage 2 Certification Greenway Intergy Meaningful Use Edition, Greenway Health, LLC, 2012-2015, 2017

Publications & Presentations

PubMed

3 citations
Efficacy and safety of switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir/abacavir/lamivudine: Results from an open-label extension of a phase...
Indira Brar, Peter J Ruane, Mezgebe Berhe, Cynthia Brinson, Paul Benson
Medicine. 2025-02-21
16 citations
Sustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks.
Charlotte-Paige Rolle, Mezgebe Berhe, Tulika Singh, Roberto Ortiz, Anson Wurapa
Open Forum Infectious Diseases. 2023-03-01
68 citations
Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-c...
Samir K Gupta, Mezgebe Berhe, Gordon Crofoot, Paul Benson, Moti Ramgopal
The Lancet. HIV. 2023-01-01

Press Mentions

Booster Shot May Be on Horizon for J&J Vaccine RecipientsAugust 25th, 2021
NTIDC Researchers: Pfizer Vaccine Is Safe, Ready to GoNovember 27th, 2020
More Than 2,500 Healthcare Providers Sign up to Administer Coronavirus Vaccine in TexasNovember 11th, 2020